Clinical Trial Update: Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adalimumab intralesional injections for intestinal strictures in Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• adalimumab intralesional (adalimumab)

Snippet

Sponsor: Sara Varea | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED